#South Korea #Seoul #Sky Labs #CART BP pro #Cuffless Monitor

Sky Labs' CART BP Pro: A Game Changer in Hypertension Management

Sky Labs, a prominent company in healthcare innovation, has recently captured the attention of the global medical community with its revolutionary product, the CART BP pro. This cuffless blood pressure monitor is not just a groundbreaking achievement; it is viewed as a potential game changer in hypertension management, setting a new standard in cardiovascular care.

Recent Symposium Highlights

On June 11, Sky Labs, led by CEO Jack ByungHwan Lee, hosted exclusive symposiums at the 35th European Society of Hypertension (ESH) in Gdańsk, Poland, and the British Cardiovascular Society (BCS) Annual Conference in Manchester, UK. These events were pivotal as they took place shortly after the Korean Society of Hypertension updated its 2026 management guidelines, which for the first time endorsed the use of validated cuffless devices for out-of-office blood pressure monitoring.

The Korean Society's endorsement is particularly significant, as South Korea is becoming a frontrunner in the clinical application of cuffless blood pressure monitors, with CART BP pro at the forefront of discussions.

Clinical Evidence and Adoption

The clinical performance of CART BP pro has been validated through extensive testing. A comparative study verified that the device meets the international standard (ISO 81060-2:2018) and adheres to the recommendations of the European Society of Hypertension by completing various tests such as Static Test, Device Position Test, Awake/Asleep Test, and Exercise Test.

Since its approval for reimbursement by South Korean health insurance in 2024, which covers 24-hour ambulatory blood pressure monitoring (ABPM), CART BP pro has seen a rapid adoption in medical institutions, with prescriptions surpassing 260,000 cases by May 2026. This rapid uptake and the device's promising clinical data have led to its growing reputation within the cardiovascular community.

Global Expert Endorsements

International experts have lauded South Korea's proactive approach towards clinical applicability of cuffless BP monitors. Professor George Stergiou, President of the International Society of Hypertension (ISH), pointed out the importance of exploring the real-world clinical utility of such devices, emphasizing that CART BP pro could significantly improve patient outcomes if its potential is realized.

Additionally, Professor Carmel McEniery of the University of Cambridge commended South Korea's advanced medical infrastructure, noting that the nation is leading in the practical use of cuffless devices. Furthermore, Professor Philip Lewis highlighted how CART BP pro mitigates the discomfort traditionally associated with cuff-based methods, paving the way for its use in both hypertension management and other medical applications.

Professor Geu-Ru Hong from Severance Cardiovascular Hospital emphasized the positive patient feedback regarding the ring-type cuffless monitor, particularly regarding nighttime use where it minimizes sleep disturbances. He views it as a significant advancement in blood pressure monitoring technology.

Regulatory Advances and Future Plans

In January 2026, Sky Labs achieved a notable milestone by receiving the European medical device certification CE-MDR, along with completing the registration of CART BP pro with the UK's Medicines and Healthcare Products Regulatory Agency (MHRA). These regulatory approvals set the stage for Sky Labs to expand further into European markets, including the UK, thereby solidifying its footprint as a global healthcare leader.

Conclusion

Sky Labs’ CART BP pro is more than just a medical device; it represents a paradigm shift in how hypertension is monitored and managed. As the device gains traction in clinical settings and garners further endorsement from medical professionals worldwide, it stands to revolutionize patient care in blood pressure management. With the potential to enhance patient compliance and health outcomes, the future appears bright for this innovative technology in the realm of cardiovascular health.

Sky Labs continues to push the boundaries of healthcare technology, reassuring stakeholders that it is at the forefront of delivering solutions that meet the evolving needs of patients and healthcare providers alike.